Imcivree

Drug Rhythm Pharmaceuticals, Inc.
Total Payments
$14.1M
Transactions
4,723
Doctors
1,077
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $6.1M 3,222 970
2022 $5.1M 1,275 167
2021 $3.0M 226 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $13.7M 2,799 97.2%
Honoraria $281,600 213 2.0%
Food and Beverage $67,875 1,557 0.5%
Travel and Lodging $38,396 105 0.3%
Consulting Fee $9,163 6 0.1%
Compensation for serving as faculty or as a speaker for a medical education program $3,187 1 0.0%
Education $1,666 42 0.0%

Payments by Type

Research
$13.7M
2,799 transactions
General
$401,887
1,924 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RM-493-034 Rhythm Pharmaceuticals, Inc. $3.0M 0
RM-493-035 Rhythm Pharmaceuticals, Inc. $2.4M 0
RM-493-014 Rhythm Pharmaceuticals, Inc. $2.3M 0
RM-493-022 Rhythm Pharmaceuticals, Inc. $2.0M 0
RHYTH001_RM 493-040_80072978 Rhythm Pharmaceuticals, Inc. $768,484 0
RM-493-030 Rhythm Pharmaceuticals, Inc. $652,003 0
RM-493-037/RM-493-022/RM-493-033 Rhythm Pharmaceuticals, Inc. $402,548 0
RM-493-023 Rhythm Pharmaceuticals, Inc. $394,051 0
RM-493-029 Rhythm Pharmaceuticals, Inc. $359,586 0
RM-493-037/RM-493-022 Rhythm Pharmaceuticals, Inc. $245,882 0
RM-493-014/RM-493-022 Rhythm Pharmaceuticals, Inc. $212,491 0
RM-493-022/ RM-493-014 Rhythm Pharmaceuticals, Inc. $202,835 0
RM-493-033 Rhythm Pharmaceuticals, Inc. $194,556 0
RM-493-037 Rhythm Pharmaceuticals, Inc. $140,511 0
RM-493-037/RM-493-033/RM-493-022 Rhythm Pharmaceuticals, Inc. $122,313 0
RM-493-013 Rhythm Pharmaceuticals, Inc. $91,949 0
RM-493-033/RM-493-022 Rhythm Pharmaceuticals, Inc. $83,888 0
RM-493-023/RM-493-014 Rhythm Pharmaceuticals, Inc. $30,897 0
RM-493-030/RM-493-022 Rhythm Pharmaceuticals, Inc. $30,469 0
RM-493-037/RM-493-033 Rhythm Pharmaceuticals, Inc. $27,606 0

Top Doctors Receiving Payments for Imcivree — Page 5

Doctor Specialty Location Total Records
, MD Internal Medicine Albuquerque, NM $141.04 2
, MD Pediatric Endocrinology Houston, TX $140.16 2
, M.D Pediatric Endocrinology Houston, TX $139.41 2
, MD., MPH Pediatrics Santa Barbara, CA $133.92 2
, PAC Physician Assistant Durham, NC $132.53 2
, PA-C Physician Assistant Durham, NC $132.53 2
, PNP Pediatrics Bend, OR $132.53 2
, PAC Physician Assistant Cincinnati, OH $132.07 2
, N.P Family Overland Park, KS $131.44 2
, MD Family Medicine Salt Lake City, UT $129.63 2
, NP Family Saint Peters, MO $129.53 2
, MD Family Medicine Laconia, NH $127.52 1
, MD Internal Medicine Boston, MA $127.52 1
, MD Family Medicine Boston, MA $127.52 1
, M.D Endocrinology, Diabetes & Metabolism Brockton, MA $127.52 1
, M.D Obesity Medicine Boston, MA $127.52 1
Michaela Olivier Student in an Organized Health Care Education/Training Program Brighton, MA $127.52 1
, MD, MPH Endocrinology, Diabetes & Metabolism Boston, MA $127.52 1
, M.D Internal Medicine Boston, MA $127.52 1
, MD Internal Medicine Boston, MA $127.52 1
, M.D Internal Medicine Boston, MA $127.52 1
, NP Nurse Practitioner Boston, MA $127.52 1
, MD Family Medicine Temple, TX $125.94 1
, M.D Pediatrics Los Angeles, CA $125.94 1
, M.D Clinical Genetics (M.D.) Los Angeles, CA $125.94 1
«1…34567…44»

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $14.1M
  • Total Doctors 1,077
  • Transactions 4,723

About Imcivree

Imcivree is a drug associated with $14.1M in payments to 1,077 healthcare providers, recorded across 4,723 transactions in the CMS Open Payments database. The primary manufacturer is Rhythm Pharmaceuticals, Inc..

Payment data is available from 2021 to 2023. In 2023, $6.1M was paid across 3,222 transactions to 970 doctors.

The most common payment nature for Imcivree is "Unspecified" ($13.7M, 97.2% of total).

Imcivree is associated with 20 research studies, including "RM-493-034" ($3.0M).